Kobe, Japan

Kei Shirasuna

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kei Shirasuna. Retrieved from https://idiyas.com/inventor/kei-shirasuna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kei Shirasuna - Innovating Cell Analysis in Kobe, Japan

Introduction

Kei Shirasuna is a distinguished inventor based in Kobe, Japan, recognized for his contributions to cell analysis technology. With a keen focus on enhancing methodologies in the biomedical field, he has developed innovative solutions that underline the critical relationship between cell structure and pathology.

Latest Patents

Shirasuna holds a notable patent for a "Cell Analysis Method, Cell Analyzer and Sample Screening Method". This patented technology entails a sophisticated approach to extracting target cells from populations derived from epithelial tissue. By utilizing the N/C ratio (nucleus to cytoplasm ratio), he classifies these cells based on DNA quantity and assesses the pathology of the epithelial tissue by comparing cell ratios against variable thresholds. This groundbreaking method signifies a leap forward in cellular diagnostics.

Career Highlights

Kei Shirasuna is affiliated with Sysmex Corporation, a company renowned for its prowess in laboratory diagnostics. His career path reflects a relentless pursuit of excellence in innovation, particularly in the realms of cytology and pathology.

Collaborations

Throughout his career, Shirasuna has collaborated with esteemed colleagues, including Ryuichiro Ebi and Shigeki Abe. These partnerships have fostered a vibrant environment for scientific exploration, supporting advancements in cell analysis methodologies and applications.

Conclusion

In conclusion, Kei Shirasuna exemplifies the spirit of innovation within the scientific community. His patented technology enhances our understanding of cellular structures and their implications in pathology, making significant contributions to the field of biomedical research and diagnostics. As he continues his work at Sysmex Corporation, his influence in advancing cell analysis techniques will undoubtedly shape future discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…